American Bio Medica Corp (ABMC) - Financial Analysis Review
American Bio Medica Corp (ABMC) - Financial Analysis Review
Summary
American Bio Medica Corp (ABMC) is a biotechnology company that develops, manufactures and markets immunoassay test kits. The company’s products include Rapid TOX, a point of collection testing (POCT) product that detects 1-10 drugs of abuse (DOA) in a urine specimen; Rapid One, a test cassette which is designed to detect a single DOA in a urine specimen; Rapid Drug Screen, detects 2 to 10 DOA in a single urine specimen; OralStat, used for the detection of DOA in oral fluids; and others.
GlobalData's American Bio Medica Corp (ABMC) - Financial Analysis Review provides a comprehensive insight into the company's history, business structure and operations. The report contains information on the company's key employees, key competitors and major products and services, as well as detailed financial ratios for the last 5 years.
American Bio Medica Corp Key Recent Developments:
Mar 31,2017: ABMC Reports Fourth Quarter and Year End 2016 Results
Nov 14,2016: ABMC Reports Third Quarter 2016 Results
Aug 15,2016: ABMC Reports Second Quarter 2016 Results
May 16,2016: ABMC Reports First Quarter 2016 Results
Mar 30,2016: ABMC Reports Fourth Quarter and Year End 2015 Results
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description - A detailed description of the company's operations and business divisions.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives' employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as detailed business description and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services.
- Examine potential investment and acquisition targets with this report's detailed insight into the company's business, financial and operational performance. Financial ratios presented for major public companies in the report include; revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.